Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEPENDAX: Axitinib + Etoposide in Pediatric Brain Tumors
NCT06485908Phase 2Not yet recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of axitinib in medulloblastoma, ependymoma, sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
axitinib
03
Conditions
medulloblastomaependymoma
Beyond the preview
Go deeper on NCT06485908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06485908.